Nava Epstein

3.8k total citations · 1 hit paper
34 papers, 2.9k citations indexed

About

Nava Epstein is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Nava Epstein has authored 34 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Immunology. Recurrent topics in Nava Epstein's work include Cardiomyopathy and Myosin Studies (9 papers), Cardiovascular Effects of Exercise (5 papers) and Muscle Physiology and Disorders (4 papers). Nava Epstein is often cited by papers focused on Cardiomyopathy and Myosin Studies (9 papers), Cardiovascular Effects of Exercise (5 papers) and Muscle Physiology and Disorders (4 papers). Nava Epstein collaborates with scholars based in United States, Israel and United Kingdom. Nava Epstein's co-authors include Lameh Fananapazir, R. Jude Samulski, Xiaodong Zhu, Xiangwei Xiao, David E. Housman, J. David Brook, Gabriel Cohn, James R. Sellers, Louis H. Miller and Julio A. Panza and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Circulation.

In The Last Decade

Nava Epstein

33 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted integration of adeno-associated virus (AAV) into human chromosome 19.

1991 601 citations J. David Brook, Nava Epstein et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nava Epstein United States	21	1.4k	1.3k	744	331	290	34	2.9k
Heinz Lother Germany	21	1.6k 1.2×	660 0.5×	628 0.8×	105 0.3×	480 1.7×	33	2.7k
Martina Sauter Germany	29	956 0.7×	1.2k 0.9×	261 0.4×	566 1.7×	643 2.2×	64	2.6k
Renate Hellmiss United States	11	1.4k 1.0×	681 0.5×	400 0.5×	76 0.2×	182 0.6×	11	2.8k
J Finidori France	31	1.1k 0.8×	216 0.2×	447 0.6×	148 0.4×	247 0.9×	55	2.6k
Jürg M. Sommer United States	24	2.0k 1.4×	282 0.2×	1.7k 2.3×	416 1.3×	96 0.3×	41	3.1k
Yuichi Watanabe Japan	24	856 0.6×	163 0.1×	684 0.9×	357 1.1×	282 1.0×	83	2.2k
Flavio Lejbkowicz Israel	21	1.0k 0.7×	325 0.2×	249 0.3×	139 0.4×	206 0.7×	55	2.0k
Nicholas W. Shworak United States	29	2.0k 1.4×	152 0.1×	494 0.7×	636 1.9×	296 1.0×	44	3.6k
Nuria Carrillo United States	20	851 0.6×	184 0.1×	333 0.4×	459 1.4×	236 0.8×	33	1.6k
Olivier Donzé Switzerland	25	2.3k 1.6×	185 0.1×	352 0.5×	289 0.9×	979 3.4×	35	3.5k

Countries citing papers authored by Nava Epstein

Since Specialization

Citations

This map shows the geographic impact of Nava Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nava Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nava Epstein more than expected).

Fields of papers citing papers by Nava Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nava Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nava Epstein. The network helps show where Nava Epstein may publish in the future.

Co-authorship network of co-authors of Nava Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Nava Epstein. A scholar is included among the top collaborators of Nava Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nava Epstein. Nava Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiser, Itay, Nadav Orr, Bella Kaufman, et al.. (2010). Immunosuppressive Treatments Reduce Long‐Term Immunity to Smallpox among Patients with Breast Cancer. The Journal of Infectious Diseases. 201(10). 1527–1534. 6 indexed citations

Weitzen, Rony, Nava Epstein, Yehuda Shoenfeld, & Eyal Zimlichman. (2007). Diagnosing Diseases by Measurement of Electrical Skin Impedance. Annals of the New York Academy of Sciences. 1109(1). 185–192. 9 indexed citations

Wolf, Ido, Hannah Kanety, Yulia Kundel, et al.. (2006). Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer. 106(4). 966–973. 151 indexed citations

Davis, Julien S., et al.. (2002). A Gradient of Myosin Regulatory Light-chain Phosphorylation across the Ventricular Wall Supports Cardiac Torsion. Cold Spring Harbor Symposia on Quantitative Biology. 67(0). 345–352. 15 indexed citations

Winichagoon, Pranee, et al.. (1998). Detection of ζ-globin chains in the cord blood by ELISA (enzyme-linked immunosorbent assay): Rapid screening for α-thalassemia 1 (Southeast Asian type). American Journal of Hematology. 57(4). 283–286. 8 indexed citations

Epstein, Nava, et al.. (1996). Monoclonal antibody‐based methods for quantitation of hemoglobins: application to evaluating patients with sickle cell anemia treated with hydroxyurea. European Journal Of Haematology. 57(1). 17–24. 13 indexed citations

Epstein, Nava, et al.. (1995). Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.. Journal of Clinical Investigation. 95(3). 1409–1414. 148 indexed citations

Fananapazir, Lameh, Nava Epstein, Rodolfo Curiel, et al.. (1994). Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.. Circulation. 90(6). 2731–2742. 232 indexed citations

Cuda, Giovanni, et al.. (1993). Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.. Journal of Clinical Investigation. 91(6). 2861–2865. 195 indexed citations

10.

Epstein, Nava, et al.. (1992). Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.. Circulation. 86(2). 345–352. 176 indexed citations

11.

Tobi, Martin, Paul Rozen, Nava Epstein, et al.. (1991). Oral colon lavage solutions containing polyethylene glycol may interfere with ELISA detection of tumor-associated antigens in colonic effluent. Digestive Diseases and Sciences. 36(10). 1448–1452. 9 indexed citations

12.

Brook, J. David, Samantha J.L. Knight, Susan Roberts, et al.. (1991). The physical map of chromosome arm 19q: some new assignments, confirmations and re-assessments. Human Genetics. 87(1). 65–72. 12 indexed citations

13.

Epstein, Nava, Omri Nahor, & Jonathan Silver. (1990). The 3' ends of alu repeats are highly polymorphic. Nucleic Acids Research. 18(15). 4634–4634. 27 indexed citations

14.

Segal, Raphael, Molly Dayan, Nava Epstein, et al.. (1989). Common variable immunodeficiency: A family study and therapeutic trial with cimetidine. Journal of Allergy and Clinical Immunology. 84(5). 753–761. 15 indexed citations

15.

Epstein, Nava, et al.. (1987). A new moderately repetitive DNa sequence family of movel organization. Nucleic Acids Research. 15(5). 2327–2341. 27 indexed citations

16.

Heaton, K W, A. P. Shepherd, Philip D. Ross, et al.. (1986). The British Society of Gastroenterology. Gut. 27(10). A1234–A1285. 2 indexed citations

17.

Aikawa, Masanori, Louis H. Miller, J Rabbege, & Nava Epstein. (1981). Freeze-fracture study on the erythrocyte membrane during malarial parasite invasion.. The Journal of Cell Biology. 91(1). 55–62. 99 indexed citations

18.

Epstein, Nava, George P. Hess, Peter S. Kim, & Richard L. Noble. (1980). Inactivation (Desensitization) of the acetylcholine receptor inElectrophorus electricus membrane vesicles by carbamylcholine: Comparison between ion flux and α-bungarotoxin binding. The Journal of Membrane Biology. 56(2). 133–137. 6 indexed citations

19.

Schejter, Abel, Amos Lanir, & Nava Epstein. (1976). Binding of hydrogen donors to horseradish peroxidase: A spectroscopic study. Archives of Biochemistry and Biophysics. 174(1). 36–44. 78 indexed citations

20.

Epstein, Nava, et al.. (1974). Proceedings: Peptide antagonists of the renin-angiotensin system and the elucidation of the receptors for angiotensin-induced drinking.. PubMed. 238(1). 34P–35P. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact